MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in MAIA Biotechnology, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q2 2025
- Shares held
- 2.37M
- +89.4K (+3.9%) vs. Q2 2025
- Total value
- $3.49M
- −$465.1K (−11.8%) vs. Q2 2025
- New holders
- 3
- 5 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,103,145 | $1.70M | 0.00% | −37,624−3.3% | Reduced |
| Centric Wealth Management | 574,898 | $712.9K | 0.16% | +1,500+0.3% | Added |
| Geode Capital Management, LLC | 271,056 | $417.5K | 0.00% | +48,873+22.0% | Added |
| Marshall Wace, LLP | 110,467 | $170.1K | 0.00% | +94,302+583.4% | Added |
| BlackRock, Inc. | 104,857 | $161.5K | 0.00% | +1,592+1.5% | Added |
| State Street Corp | 75,550 | $116.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 39,032 | $60.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 36,000 | $55.4K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 14,800 | $26.5K | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisory Group | 15,730 | $24.2K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,615 | $17.9K | 0.00% | +11,615 | New |
| Advisor Group Holdings, Inc. | 8,334 | $12.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,026 | $6.20K | 0.00% | +2,179+118.0% | Added |
| Curio Wealth, LLC | 2,000 | $3.08K | 0.00% | +2,000 | New |
| Morgan Stanley | 832 | $1.28K | 0.00% | −4,263−83.7% | Reduced |
| MAI Capital Management | 675 | $1.04K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 530 | $816 | 0.00% | +530 | New |
| Jones Financial Companies LLLP | 228 | $369 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 29 | $45 | 0.00% | −202−87.4% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −28,783−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,120−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −50−100.0% | Sold out |